533 related articles for article (PubMed ID: 33074528)
1. Metabolism and immunity in breast cancer.
Zhang D; Xu X; Ye Q
Front Med; 2021 Apr; 15(2):178-207. PubMed ID: 33074528
[TBL] [Abstract][Full Text] [Related]
2. Perspectives of Reprogramming Breast Cancer Metabolism.
Wang YP; Lei QY
Adv Exp Med Biol; 2017; 1026():217-232. PubMed ID: 29282686
[TBL] [Abstract][Full Text] [Related]
3. Potential Therapeutic Targets in Energy Metabolism Pathways of Breast Cancer.
Islam RA; Hossain S; Chowdhury EH
Curr Cancer Drug Targets; 2017; 17(8):707-721. PubMed ID: 28359244
[TBL] [Abstract][Full Text] [Related]
4. Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer.
Shum HCE; Wu K; Vadgama J; Wu Y
J Pers Med; 2023 Jan; 13(1):. PubMed ID: 36675817
[TBL] [Abstract][Full Text] [Related]
5. Leptin regulates energy metabolism in MCF-7 breast cancer cells.
Blanquer-Rosselló MDM; Oliver J; Sastre-Serra J; Valle A; Roca P
Int J Biochem Cell Biol; 2016 Mar; 72():18-26. PubMed ID: 26772821
[TBL] [Abstract][Full Text] [Related]
6. Oncoprotein HBXIP Modulates Abnormal Lipid Metabolism and Growth of Breast Cancer Cells by Activating the LXRs/SREBP-1c/FAS Signaling Cascade.
Zhao Y; Li H; Zhang Y; Li L; Fang R; Li Y; Liu Q; Zhang W; Qiu L; Liu F; Zhang X; Ye L
Cancer Res; 2016 Aug; 76(16):4696-707. PubMed ID: 26980761
[TBL] [Abstract][Full Text] [Related]
7. Targeting Key Metabolic Enzymes Involved in Lipid and Protein Biosyntheses for Breast Anticancer Therapies.
Guerram M; Hamdi AM; Zhang LY; Jiang Z
Curr Cancer Drug Targets; 2017; 17(2):158-168. PubMed ID: 27262320
[TBL] [Abstract][Full Text] [Related]
8. Emerging functional roles of nuclear receptors in breast cancer.
Doan TB; Graham JD; Clarke CL
J Mol Endocrinol; 2017 Apr; 58(3):R169-R190. PubMed ID: 28087820
[TBL] [Abstract][Full Text] [Related]
9. TRIM28 multi-domain protein regulates cancer stem cell population in breast tumor development.
Czerwińska P; Shah PK; Tomczak K; Klimczak M; Mazurek S; Sozańska B; Biecek P; Korski K; Filas V; Mackiewicz A; Andersen JN; Wiznerowicz M
Oncotarget; 2017 Jan; 8(1):863-882. PubMed ID: 27845900
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities.
Xiong H; Zhao W; Wang J; Seifer BJ; Ye C; Chen Y; Jia Y; Chen C; Shen J; Wang L; Sui X; Zhou J
Oncotarget; 2017 Apr; 8(15):25721-25735. PubMed ID: 28147339
[TBL] [Abstract][Full Text] [Related]
11. Metabolic crosstalk in the breast cancer microenvironment.
Dias AS; Almeida CR; Helguero LA; Duarte IF
Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
[TBL] [Abstract][Full Text] [Related]
12. The pan-cancer mutational landscape of the PPAR pathway reveals universal patterns of dysregulated metabolism and interactions with tumor immunity and hypoxia.
Chang WH; Lai AG
Ann N Y Acad Sci; 2019 Jul; 1448(1):65-82. PubMed ID: 31215667
[TBL] [Abstract][Full Text] [Related]
13. The lipid metabolism remodeling: A hurdle in breast cancer therapy.
Xiao Q; Xia M; Tang W; Zhao H; Chen Y; Zhong J
Cancer Lett; 2024 Feb; 582():216512. PubMed ID: 38036043
[TBL] [Abstract][Full Text] [Related]
14. Roles of fatty acid metabolism in tumourigenesis: Beyond providing nutrition (Review).
Yu XH; Ren XH; Liang XH; Tang YL
Mol Med Rep; 2018 Dec; 18(6):5307-5316. PubMed ID: 30365095
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Silencing of TAP1 in Aldefluor
Sultan M; Vidovic D; Paine AS; Huynh TT; Coyle KM; Thomas ML; Cruickshank BM; Dean CA; Clements DR; Kim Y; Lee K; Gujar SA; Weaver ICG; Marcato P
Stem Cells; 2018 May; 36(5):641-654. PubMed ID: 29341428
[TBL] [Abstract][Full Text] [Related]
16. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
[TBL] [Abstract][Full Text] [Related]
17. Lipid Metabolism and Tumor Antigen Presentation.
Qin H; Chen Y
Adv Exp Med Biol; 2021; 1316():169-189. PubMed ID: 33740250
[TBL] [Abstract][Full Text] [Related]
18. Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based "starvation" strategies in BRCA1 carriers.
Cuyàs E; Fernández-Arroyo S; Alarcón T; Lupu R; Joven J; Menendez JA
Oncotarget; 2016 Aug; 7(33):52974-52992. PubMed ID: 27259235
[TBL] [Abstract][Full Text] [Related]
19. Stem cells of the breast and cancer therapy.
Groner B; Vafaizadeh V; Brill B; Klemmt P
Womens Health (Lond); 2010 Mar; 6(2):205-19. PubMed ID: 20187727
[TBL] [Abstract][Full Text] [Related]
20. 2-methoxyestradiol impacts on amino acids-mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor.
Gorska-Ponikowska M; Perricone U; Kuban-Jankowska A; Lo Bosco G; Barone G
J Cell Physiol; 2017 Nov; 232(11):3030-3049. PubMed ID: 28262924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
